Shares of Nextgen Healthcare Inc (NASDAQ:NXGN) have been assigned a consensus recommendation of “Hold” from the twelve brokerages that are covering the firm, MarketBeat.com reports. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and three have issued a buy rating on the company. The average 12 month price target among brokerages that have updated their coverage on the stock in the last year is $16.00.
A number of research firms have weighed in on NXGN. Dougherty & Co raised Nextgen Healthcare from a “sell” rating to a “neutral” rating and set a $1.00 target price on the stock in a report on Tuesday, September 17th. KeyCorp raised Nextgen Healthcare from an “underweight” rating to a “sector weight” rating in a report on Thursday, August 29th. They noted that the move was a valuation call. ValuEngine downgraded Nextgen Healthcare from a “buy” rating to a “hold” rating in a report on Thursday, October 31st. Jefferies Financial Group set a $16.00 target price on Nextgen Healthcare and gave the company a “hold” rating in a report on Friday, August 23rd. Finally, TheStreet raised Nextgen Healthcare from a “c+” rating to a “b” rating in a report on Thursday, October 24th.
Hedge funds have recently bought and sold shares of the business. Swiss National Bank lifted its holdings in Nextgen Healthcare by 2.1% in the second quarter. Swiss National Bank now owns 90,300 shares of the company’s stock valued at $1,797,000 after acquiring an additional 1,900 shares during the period. Smith Graham & Co. Investment Advisors LP raised its stake in shares of Nextgen Healthcare by 1.5% in the second quarter. Smith Graham & Co. Investment Advisors LP now owns 501,595 shares of the company’s stock worth $9,982,000 after buying an additional 7,497 shares during the period. Allianz Asset Management GmbH raised its stake in shares of Nextgen Healthcare by 139.9% in the second quarter. Allianz Asset Management GmbH now owns 159,082 shares of the company’s stock worth $3,165,000 after buying an additional 92,781 shares during the period. Wells Fargo & Company MN raised its stake in shares of Nextgen Healthcare by 1.7% in the second quarter. Wells Fargo & Company MN now owns 95,048 shares of the company’s stock worth $1,891,000 after buying an additional 1,594 shares during the period. Finally, Aperio Group LLC raised its stake in shares of Nextgen Healthcare by 14.2% in the second quarter. Aperio Group LLC now owns 17,600 shares of the company’s stock worth $350,000 after buying an additional 2,183 shares during the period. 70.43% of the stock is currently owned by institutional investors.
Shares of Nextgen Healthcare stock traded down $0.05 during trading on Monday, hitting $16.84. 122,100 shares of the company’s stock traded hands, compared to its average volume of 270,187. The company has a debt-to-equity ratio of 0.11, a current ratio of 1.29 and a quick ratio of 1.29. Nextgen Healthcare has a 1 year low of $13.60 and a 1 year high of $21.12. The stock has a market capitalization of $1.13 billion, a P/E ratio of 27.61, a PEG ratio of 4.55 and a beta of 1.04. The business has a 50-day simple moving average of $16.17 and a 200-day simple moving average of $17.36.
Nextgen Healthcare (NASDAQ:NXGN) last released its quarterly earnings data on Wednesday, October 23rd. The company reported $0.24 EPS for the quarter, beating the consensus estimate of $0.23 by $0.01. Nextgen Healthcare had a return on equity of 10.05% and a net margin of 3.02%. The company had revenue of $134.30 million for the quarter, compared to analysts’ expectations of $134.39 million. During the same period last year, the firm posted $0.24 earnings per share. Nextgen Healthcare’s revenue was up 3.1% compared to the same quarter last year. On average, equities analysts predict that Nextgen Healthcare will post 0.63 earnings per share for the current fiscal year.
Nextgen Healthcare Company Profile
NextGen Healthcare, Inc provides software, services, and analytics solutions to medical and dental group practices in the United States. The company's principal products include NextGen Enterprise EHR, which stores and maintains clinical patient information; and a workflow module, prescription management, automatic document and letter generation, patient education, referral tracking, interfaces to billing and lab systems, physician alerts and reminders, and reporting and data analysis tools.
Featured Article: Google Finance Portfolio
Receive News & Ratings for Nextgen Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nextgen Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.